Arsenic is the most ubiquitous environmental toxin. Here, we demonstrate that bacteria have evolved the ability to use arsenic to gain a competitive advantage over other bacteria at least twice. Microbes generate toxic methylarsenite (MAs(III)) by methylation of arsenite (As(III)) or reduction of methylarsenate (MAs(V)). 
Introduction
Arsenic is the most ubiquitous environmental toxin in soil and water. The concentration of arsenic and other toxic metals and metalloids was high in primordial anoxic oceans and hydrothermal vents, where life likely first arose, presenting a challenge for the first organisms (Kulp, 2014; Fru et al., 2015; Chen et al., 2017) . This intense selective pressure was the driving force for the early evolution of bacterial arsenic resistance (ars) genes and pathways in the primal anoxic atmosphere (Chen et al., 2017) . These pathways are found in nearly every extant organism; without arsenic detoxification systems, it is questionable if life could have arisen. Here, we demonstrate that life has not only adapted to survive in the presence of arsenic, but to use it as an offensive weapon against competitors.
Our central hypothesis is that early bacteria evolving about 3 Bya in an oxygen-free atmosphere, methylated arsenic with the enzyme ArsM, an As(III) S-adenosylmethionine (SAM) methyltransferase (Qin et al., 2006) , producing highly toxic methylarsenite (MAs(III)), which they exported to kill other microbes (Li et al., 2016; Chen et al., 2017) . In the early 1940s, Selman Waksman first defined the term 'antibiotic' as 'a chemical substance, produced by micro-organisms, which has the capacity to inhibit the growth of and even to destroy bacteria and other micro-organisms' (Waksman, 1947) , a definition that would certainly include MAs(III). The same argument might be made for DMAs (III) , but that species is very reactive and unstable, which makes it difficult to analyze, so this study is limited to MAs(III).
ArsM orthologs are widespread and are found in members of every kingdom from bacteria to humans (Table  S1) . A second gene, arsP, arose concurrently with arsM (Chen et al., 2017) . ArsP is an MAs(III) efflux permease that confers resistance to the trivalent organoarsenical (Chen, Madegowda et al., 2015) . Many organisms that produce antibiotics have efflux permeases that protect themselves from their own antibiotics, and their genes have moved to other microbes to spread antibiotic resistance (D'Costa et al., 2007) . ArsP may have had a similar physiological role in the original MAs(III) producers, and other bacteria could have acquired an arsP gene by lateral gene transfer to confer MAs(III) resistance. ArsP is made by many species of bacteria and archaea but is not found in eukaryotes (Table S1 ). Both ArsM and ArsP are found in anaerobes, consistent with an early co-evolution in an anoxic environment (Chen et al., 2017) . Quite recently, an additional efflux permease for As(III), Sb(III), Rox(III) and MAs(III) that confers resistance to those arsenicals was identified in an ars operon from Agrobacterium tumefaciens GW4 (Shi et al., 2018) . ArsK is widely distributed in bacteria but not in archaea, fungi, plants or animals.
Subsequent to the Great Oxidation Event (GOE) about 2.5 Bya, trivalent MAs(III) would have been oxidized to the much less toxic pentavalent species MAs(V) (Fru et al., 2015) . In a number of extant microorganisms with an arsM gene, methylation is an As(III) detoxification mechanism for microbes under aerobic growth (Qin et al., 2006; Ye et al., 2012) . In an aerobic environment, MAs(III) is constantly oxidized to MAs(V), and members of present microbial communities continually reduce MAs(V) to MAs(III) (Yoshinaga et al., 2011) . We propose that they do so to generate MAs(III) for use as an antibiotic in the continual warfare that takes place between organisms in microbial jungles (Hibbing et al., 2010) . In addition, anthropogenic use of the herbicide monosodium methylarsenate (MSMA) provides another source of MAs(V) for microbial reduction (Feng et al., 2005; Yoshinaga et al., 2011) . The ability to reduce both biogenic and anthropogenic pentavalent organoarsenicals for antibiotic production confers an additional selective advantage for those bacteria. This capacity of soil bacteria to create more complex systems as a collective is an emergent property of microbial communities (Mayr, 1982) .
Paul Ehrlich prophesied that 'drug resistance follows the drug like a faithful shadow' (Sheps and Ling, 2007) . In response to this intense selective pressure, aerobic mechanisms for MAs(III) resistance evolved. ArsH is an NADP + / FMNH 2 oxidoreductase that confers resistance to MAs(III) by oxidation to MAs(V) . ArsI is a C-As lyase that degrades MAs(III) to less toxic As(III) . ArsH is found primarily in aerobic bacteria, although orthologs have been identified in fungi and opisthokonts (Table S1 ). ArsI has been identified only in aerobic bacteria (Table S1 ). The fact that both ArsH and ArsI require oxygen and are found only in aerobes is consistent with evolution following the GOE. Thus, MAs(III) has the classical properties of an antibiotic, a toxic compound produced by one microbe to kill off competitors, and, in response, aerobic microbes have adapted by acquiring MAs(III) resistance mechanisms.
To test our hypothesis, we examined the antimicrobial properties of MAs(III). Cells of E. coli expressing an arsM gene methylated As(III), and cells that co-expressed arsM and arsP genes produced even more extracellular MAs(III). In co-culture, the MAs(III)-producing strain (predator) reduced the viability of an MAs(III)-sensitive strain of E. coli (prey). Several species of soil microbes could reduce MAs(V) to MAs(III), including the environmental isolate Burkholderia sp. MR1 (Yoshinaga et al., 2011) . Growth of the MAs(V) reducer decreased the viability of the MAs(III)-sensitive strain of E. coli. Thus, production of MAs(III) by either methylation of As(III) or reduction of MAs(V) increased toxicity in situ. Expression of ArsH, ArsI or ArsP reversed toxicity to E. coli in co-culture with Burkholderia sp. MR1. These results are consistent with our hypothesis that members of microbial communities produce MAs(III) as an antibiotic, and that other community members bacteria have adapted by acquisition of specific MAs(III) resistance mechanisms.
Results

MAs(III) is produced biologically either by methylation of As(III) or reduction of MAs(V)
In an aerobic environment, arsenicals are found primarily as the relatively nontoxic pentavalent species. This includes inorganic As(V) and MAs(V) and dimethylarsenate (DMAs(V)). Microbial or chemical reduction of these arsenicals make them highly toxic to bacteria in the order MAs(III)=DMAs(III)>>As(III)>>As(V)>MAs(V)=D-MAs(V) . MAs(III) can be generated biologically in two ways. The first is methylation of inorganic As(III) by As(III) S-adenosylmethionine (SAM) methyltransferases, which are called ArsM in microbes and AS3MT in animals (Qin et al., 2006) . To illustrate this, cells of E. coli expressing a recombinant arsM gene from the soil alga Chlamydomonas reinhardtii (Chen et al., 2013) were incubated with As(III). After four hours with shaking in air, both methylated and dimethylated arsenicals were found in the extracellular medium (Fig. 1) . We showed previously that ArsM and AS3MT initially produce MAs(III), which is either methylated a second time to dimeth- ylarsenite (DMAs(III)) or is oxidized to MAs(V) in air (Marapakala et al., 2012; Dheeman et al., 2014) . Under aerobic conditions, DMAs(III) is unstable and rapidly oxidized to DMAs(V) (Le et al., 2000) , which is the species found in the growth medium. The antibiotic properties of DMAs(III) could not be investigated because of its instability. When the initial oxidation state cannot be determined, the species is simply designated as MAs or DMAs. The second route of generation of environmental MAs(III) is microbial reduction of MAs(V) by soil bacteria (Fig. 1) . Four different species of bacteria, Pseudomonas putida KT2440 (Yoshinaga et al., 2011) , Burkholderia sp. MR1 (Yoshinaga et al., 2011) , Shewanella putrefaciens 200 (Chen and Rosen, 2016) and Sinorhizobium meliloti RM1021 are capable of reducing MAs(V), demonstrating that multiple soil bacteria have the ability to reductively generate MAs(III). Neither E. coli ArsC (Oden et al., 1994) nor yeast Acr2p (Mukhopadhyay et al., 2000) reduce MAs(V) (unpublished results), and the pathway/genes/enzymes involved in MAs(V) reduction are as yet unknown.
MAs(III) has antibiotic properties when produced by either biomethylation of As(III) or microbial reduction of MAs(V)
The bioavailability and toxicological effects of arsenic are highly dependent on its chemical form and oxidation state. Pentavalent arsenicals are generally less bioavailable and toxic than the trivalent species, so organoarsenical herbicides and antimicrobial growth promoters are applied in their pentavalent forms, with subsequent microbial reduction. While synthetic trivalent organoarsenicals are more toxic than As(III) (Chen et al., 2013) , only MAs(III) is a natural product produced by soil microbes. ArsM is predicted to have evolved more than 3 Bya, when the atmosphere was anoxic (Chen et al., 2017) . In the absence of oxygen, the products of methylation would be primarily trivalent, which implies that ArsM methylation did not evolve as a mechanism for arsenic detoxification. We propose that the original function of ArsM methylation was to produce MAs(III) as an antibiotic to give them a competitive advantage (Li et al., 2016; Chen et al., 2017) . To survival under the selective pressure of MAs(III) production, other soil bacteria evolved arsI, arsH and arsP genes that encode proteins that detoxify MAs(III) by degradation (ArsI) or oxidation (ArsH) or for tolerance by active efflux (ArsP).
It is not clear how trivalent organoarsenicals are released from cells, although downhill efflux through aquaglyceroporins such as the S. meliloti AqpS is one possibility (Yang et al., 2005) . ArsP is the only active efflux permease selective for a trivalent organoarsenical and is predicted to have co-evolved with ArsM, perhaps to extrude MAs(III) from producing cells both for their own protection from MAs(III) toxicity and to increase the effectiveness of MAs(III) as an antibiotic (Chen et al., 2017) . To examine whether ArsP facilitates efflux of MAs(III) produced by ArsM, the arsM gene (Chen et al., 2013) was co-expressed with an arsP gene from Campylobacter jejuni (Chen, Madegowda et al., 2015) , and production of extracellular methylated arsenicals determined (Fig. 2) . Cells expressing only ArsM produced more extracellular DMAs than MAs. In cells expressing both arsM and arsP, the profile was shifted toward production of extracellular MAs(III), with decreased synthesis of DMAs. Since MAs(III) is both the product of the first methylation step and the substrate for the second, removal of MAs(III) from the cytosol reduces the rate of DMAs synthesis and more MAs(III) production.
Our hypothesis that MAs(III) is an antibiotic implies that cells that generate extracellular MAs(III) would have a competitive advantage over MAs(III)-sensitive members of microbial communities. To test this idea, a microbial community was simulated by co-culture of E. coli AW3110 co-expressing an arsM gene with or without an arsP gene along with cells of the same strain E. coli AW3110 expressing the gene for green fluorescence protein (GFP) as measure of viability (Fig. 3) . The GFP reporter strain grew equally well in the absence of As(III) or the presence of a subtoxic concentration (20 μM) of As(III). When co-cultured with cells expressing the arsM gene in the presence of As(III), there was a reduction in viability of the GFP reporter strain after 12 days. Viability ArsP. Cells of E. coli AW3110 bearing arsM with or without arsP were cultured in LB medium overnight as described in Experimental Procedures. As(III) were added at 10 μM, final concentration, to the cell suspensions, and incubated at 37°C with shaking for an additional 6 h. Arsenicals in the culture medium were speciated by HPLC using a C18 reverse phase column, and the amount of arsenic was estimated by ICP-MS. The cartoons indicate pathways of methylation and efflux. Top: without ArsP, methylation favors formation of DMAs. Cells with ArsP extrude MAs(III) before the second round of methylation occurs, leading to increased MAs and decreased DMAs production.
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was reduced considerably more when the MAs(III) producer also expressed the arsP gene in co-culture with the GFP reporter strain. These results clearly demonstrate that microbial production of MAs(III) kills sensitive bacteria and in consistent with our hypothesis that environmental bacteria that produce MAs(III) have an growth edge in microbial communities. After the Great Oxidation Event (GOE), atmospheric O 2 would have favored the oxidation of most environmental MAs(III) to MAs(V) after leaving the cells of producers. This marks a transition in the function of ArsM/AS3MT from toxin production to detoxification. The major source of environmental MAs(III) is now reduction of MAs(V) by aerobic soil bacteria. In microbial communities, MAs(V) reducers would have a selective advantage over other bacteria, which would be sensitive to the resulting MAs(III). To test this idea, a microbial community was simulated by co-culture of Burkholderia sp. MR1, an environmental isolate that reduces MAs(V), with the E. coli GFP reporter strain with or without MAs(V) (Fig. 4) . In the absence of MAs(V), the GFP reporter strain grew well in the presence of MAs(V), but addition of 20 μM MAs(V) resulted in loss of viability of the reporter strain over a period of 12 days in mixed culture with the reducing strain. During this time period, Burkholderia sp. MR1 reduced 50% of the MAs(V) to MAs(III), and that strain continued to grow, demonstrating a competitive advantage for the MAs(V) reducer. Again, these results support our hypothesis that environmental bacteria that produce MAs(III) out-compete other members of microbial communities.
Microbial resistance to MAs(III)
Within microbial communities there is constant warfare between antibiotic producers and antibiotic resistant bacteria. While the arsP gene may have conferred resistance prior the GOE, the availability of oxygen provided new opportunities for MAs(III) detoxification. ArsI and ArsH both require molecular oxygen for catalysis and can be predicted to have evolved as MAs(III) resistances subsequent to ArsM and ArsP. The relative effectiveness of expression of each gene for conferral of MAs(III) resistance was compared in the same strain with the same promoter (Fig. 5) . The ability to confer resistance was in the order ArsP>ArsH=ArsI>>ArsM. The same order of resistance was observed when MAs(III) was generated in situ by co-culturing Burkholderia sp. MR1 with the GFP reporter strain (Fig. 6) . The relatively poor resistance conferred by ArsM indicates that its physiological role in bacteria is production of and not resistance to MAs(III). The membrane protein ArsP is produced in low amounts (Chen, Madegowda et al., 2015) , suggesting that efflux is a more effective mechanism for resistance than enzymatic biotransformation.
Discussion
There is no question that bacteria evolved at least 3 Bya in an anoxic environment that was filled with toxic metals in mixed culture. Cells of E. coli AW3110 bearing arsM (predator 1) or arsM and arsP (predator 2) and E. coli AW3110 bearing pACYC184-Pars-gfp (prey) were co-cultured in the presence (open symbols) or absence (closed symbols) of a nontoxic concentration (20 μM) of As(III), as described under Experimental Procedures, and viability of the prey cells was estimated from GFP fluorescence. Cells: circles, prey; squares, both predator 1 and prey; triangles; both predator 2 and prey. Fluorescence intensities of the cell suspensions were quantified by spectrofluorometry. The data are the mean ± SE (n = 3). and metalloids such as arsenic. Arsenic is considered as only a poison, and no essential role in metabolism has been found. Indeed, some microbes gain energy from oxidizing arsenite. Arsenite oxidation may serve as an energy source in chemolithotrophic microorganisms (Silver and Phung, 2005) . Some anaerobic bacteria are also able to use dissimilatory arsenate reduction for energy generation, which gives those microbes a competitive advantage for growth (Oremland and Stolz, 2003) . Arsenic species may have been involved in the ancestral taming of energy and played a crucial role in early stages in the development of life on Earth.
In this study, we identify a second role for arsenic in biology, its use in generation of the antibiotic MAs(III). Since the origin of life bacteria have fought to gain dominance over their neighbors (Hibbing et al., 2010) . Evolution of pathways leading to antibiotic production was a major stratagem in primordial warfare, just as evolution of resistance mechanisms was the prey's parry. Our hypothesis that the trivalent organoarsenical MAs(III) was an early antibiotic is similar to the well-documented situation with known antibiotics. At present, MAs(III) is produced by microbial communities by several independent mechanisms. We propose that these evolved long before anthropogenic use of organoarsenical herbicides, just as antibiotics have always been produced world-wide in microbial communities at low levels. In response, other members of microbial communities have evolved mechanisms for antibiotic resistance. This goes on continuously in the environment. Anthropogenic use of antibiotics in hospitals, in animal husbandry and other settings has spread resistance determinants. In the same way, use of MAs(V) as an herbicide may amplify MAs(III) production.
The first way that MAs(III) is produced in micriobial communities is As(III) methylation by bacteria with an arsM gene, which evolved more than 2.5 Bya (Chen et al., 2017) . This is a relatively straight-forward adaptation, where a single enzyme generates toxic MAs(III). However, once the atmosphere became oxygenated, trivalent arsenicals were the less toxic oxidized species, and, in aerobes, ArsM switched its role from toxin formation to detoxification (although it may retain the original role in anaerobes). This opened a new opportunity for other bacteria to take over the role of generation of the MAs(III) antibiotic by reduction of MAs(V), and other bacteria adapted yet again by acquisition of aerobic mechanisms to detoxify MAs(III). An emergent property of microbial communities exists when one microbe produces a compound that a second transforms into an antibiotic that a third detoxifies, a level of complexity that cannot be predicted from the properties of each individual species (Mayr, 1982) .
It is not easy to recapitulate those evolutionary steps, but it is possible to demonstrate that extant bacteria have the capability to kill competitors by generation of MAs(III), and that other members of the same soil community detoxify MAs(III) by efflux, degradation, or oxidation (Fig. 7) . To date, most of the major enzymes in these pathways have been identified: ArsM catalyzes As(III) methylation, ArsP catalyzes MAs(III) efflux, ArsH oxidizes MAs(III), and ArsI degrades MAs(III). The major source of environmental methylated arsenicals is ArsM-catalyzed methylation As(III) by bacteria, archaea and eukaryotic microbes . In addition, MAs(V) is introduced as an herbicide (Feng et al., 2005) . The missing link in understanding interactions in microbial communities is the mechanism of MAs(V) reduction. Several bacterial strains have been identified that are capable of reducing MAs(V), including the environmental isolate Burkholderia sp. MR1 (Yoshinaga et al., 2011) , as well as S. putrefaciens 200 (Chen and Rosen, 2016) , P. putida KT2440 (Yoshinaga et al., 2011) , and S. meliloti RM1021. To date, no specific genes/enzymes involved in MAs(V) reduction have been identified. A derivative of P. putida in which both ars operons had been deleted retained the ability to reduce MAs(V) (Yoshinaga et al., 2011) , indicating that the pathway is independent of classic arsenic resistance pathways. Interestingly, both Burkholderia sp. MR1 and P. putida KT2440 reduce MAs(V) in nutrient-poor media but not in rich media such as lysogeny broth (LB) broth (Yoshinaga et al., 2011) . This suggests that reduction may be a response to nutrient limitation, where the competition between MAs(III) producers and their neighbors for space and resources becomes more imperative. Identification of the pathway(s) and its nutritional regulation is our next frontier. In summary, the data presented here support our hypothesis that MAs(III) is continuously produced by members of soil microbial communities to serve as an antibiotic, and that MAs(III) resistance is the response of other community members. A more rigorous test of our concept requires broad environmentally based studies such as a comparative metagenomics study of microbial communities in golf course soil, where MSMA was used, against communities in soils that have no known history of MAs(V) exposure. Strains, plasmids, media, and reagents Strains and plasmids used in this study are described in Table S2 . E. coli Stellar™ (Clontech Laboratories, Mountain View, CA) TOP10 (Invitrogen, Carlsbad, CA) were used for plasmid DNA construction and replication. In most experiments cultures of E. coli strain AW3110(DE3) ∆arsRBC (Carlin et al., 1995) bearing plasmids as indicated were grown aerobically in LB medium or M9 basal salts medium at 37°C supplemented with 50 μg ml −1 kanamycin or 34 μg ml −1 chloramphenicol, as required (Sambrook et al., 1989) . Growth was monitored by measuring the absorption at 600 nm (A 600nm ). P. putida KT2440, S. meliloti RM1021, Burkholderia sp. MR1, and S. putrefaciens 200 cells were grown aerobically at 30°C in LB medium or M9 medium without antibiotics, as indicated. Unless otherwise indicated, all reagents were purchased from Sigma-Aldrich. MAs(V) was obtained as MSMA from Chem Service, Inc., West Chester, PA (N-12495-100 MG), and was reduced chemically to MAs(III) by the method of Reay and Asher (Reay and Asher, 1977) .
Experimental procedures
Generation of MAs(III) by As(III) methylation or MAs(V) reduction
To analyze MAs(III) generation from either As(III) methylation or MAs(V) reduction, cells were cultured in LB overnight at 30°C, then washed twice with ST 10 −1 medium (Maki et al., 2009 ) supplemented with 0.2% D-glucose. The cells were then suspended in either M9 medium or ST10 −1 medium, as indicated, and cell density was adjusted to A 600 = 3.0. For methylation, As(III) was added at 10 μM, final concentration, to the E. coli cell suspension with or without arsM, and further incubated at 37°C with shaking for 4 h. For reduction, MAs(V) was added at 4 μM, final concentration, to the indicated bacteria and incubated at 30°C with shaking for 4 h. Arsenical products in the culture medium were speciated by high-performance liquid chromatography (HPLC) (Series 2000; Perkin-Elmer, Waltham, MA) using a Jupiter ® 5 μm C18 300 Å reverse-phase column (250 mm × 4.6 mm; Phenomenex, Torrance, CA) eluted isocratically with a mobile phase consisting of 3 mM malonic acid, 5 mM tetrabutylammonium hydroxide and 5% methanol (v/v), pH 5.6, with a flow rate of 1 ml min −1 at 25°C. Arsenic concentrations were determined by inductively coupled plasma mass spectroscopy (ICP-MS) (ELAN DRC-e; Perkin-Elmer).
Resistance assays
To assay resistance to MAs(III), cells of AW3110 with or without ars genes (arsP, arsH, arsI, arsM) were cultured in LB medium overnight at 37°C with 0.2 mM isopropyl β-D-1-thiogalactopyranoside and required antibiotics. The cultures were then diluted 100-fold into fresh M9 medium with 0.2% glucose containing the indicated concentrations of MAs(III). The cultures were incubated at 37°C with shaking for an additional 24 h. Growth was estimated from the A 600nm . To analyze toxicity of MAs(III) generated by methylation of As(III) in situ, cells of E. coli AW3110 bearing a plasmid with the arsM gene and, as indicated, the arsP gene (predator) were grown in co-culture with E. coli AW3110 bearing pACYC184-Pars-gfp (prey) in M9 minimal medium at 37°C with shaking to an A 600nm = 2.0. The mixture was diluted 100-fold in M9 medium containing 0.2% glucose and 20 μM As(III), adjusted to A 600nm = 0.02, and incubated at 30°C with shaking for 24 h. This process was repeated daily for 12 days, and GFP fluorescence was measured each day to estimate viability of the prey cells (Chen et al., 2014) . To analyze toxicity of MAs(III) generated by reduction of MAs(V) in situ, cells of Burkholderia sp. MR1 (predator) and E. coli AW3110 bearing pACYC184-Pars-gfp (prey) were added at a 2:1 ratio and grown to an A 600nm = 2.0) in M9 medium containing 0.2% glucose at 30°C with shaking. The mixture was diluted 100-fold in M9 medium containing 0.2% glucose and 20 μM MAs(V), adjusted to A 600nm = 0.02, and incubated at 30°C with shaking. Each day the culture density was re-adjusted to A 600nm = 0.02, and the process was repeated for 12 days, with GFP fluorescence measured each day to estimate viability of the prey cells. Fluorescence was measured by using a Photon Technology International Spectrofluorometer with an excitation wavelength of 470 nm and emission wavelength of 510 nm.
Distribution of MAs(III) resistance genes
Clusters of Orthologous Groups (COG) entries associated with CmArsM (Cyanidioschyzon merolae sp. 5508), ENOG410IFW3, were used to extract ArsM sequences in the eggNOG database (Powell et al., 2014) . Only those sequences containing at least three of the four conserved cysteine residues corresponding to residues 44, 72, 174, and 224 in CmArsM were included (Marapakala et al., 2012) . To obtain sequences of arsP genes encoding candidate orthologs, ArsP (Campylobacter jejuni RM1221), ENOG4105DSX, was used. Only those sequences containing a highly conserved motif (TPFCSCSXXP) were included (Chen, Madegowda et al., 2015) . To obtain sequences of arsH genes encoding candidate orthologs, PpArsH (P. putida KT2440), ENOG4105CAU, was used . Only arsH genes in arsenic operons were included. To obtain sequences of arsI genes encoding candidate orthologs, BsArsI (Bacillus sp. MD1), ENOG4108YZ3, was used. Only those sequences containing a vicinal cysteine pair of corresponding to residues in the MAs(III) binding site of BsArsI were included .
